Rapid diagnostic testing to improve access to screening for syphilis in prison.

dc.contributor.authorK Montaño
dc.contributor.authorA Flores
dc.contributor.authorM Villarroel-Torrico
dc.contributor.authorN Cossio
dc.contributor.authorA Salcedo-Meneses
dc.contributor.authorC Valencia-Rivero
dc.contributor.authorR Castro-Soto
dc.contributor.authorG Gétaz-Jiménez
dc.contributor.authorHans Wolff
dc.contributor.authorH Bermúdez-Paredes
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T17:56:05Z
dc.date.available2026-03-22T17:56:05Z
dc.date.issued2019
dc.description.abstractThe rapid syphilis test Determine shows excellent performance as a screening tool among women deprived of liberty affected by high prevalence of syphilis. This test is particularly indicated when there are barriers for access to conventional serological tests. It is inexpensive, easy to use and does not require electricity and laboratory infrastructure. The FTA test performed with reagents from Biocientífica had a suboptimal sensitivity.
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/30908570
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/67120
dc.language.isoen
dc.publisherNational Institutes of Health
dc.relation.ispartofPubMed
dc.sourceUniversity of San Simón
dc.subjectSyphilis
dc.subjectMedicine
dc.subjectSerology
dc.subjectTest (biology)
dc.subjectGynecology
dc.titleRapid diagnostic testing to improve access to screening for syphilis in prison.
dc.typearticle

Files